These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27473275)

  • 1. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
    Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK
    Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
    Achilles SL; Kelly CW; Hoesley CJ; Blithe DL; Brown J; Richardson BA; Devlin B; Hendrix CW; Poloyac SM; Marzinke MA; Gundacker H; Singh D; Piper JM; Johnson S; Steytler J; Chen BA;
    PLoS One; 2024; 19(6):e0304552. PubMed ID: 38838028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device.
    Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK
    J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
    Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
    J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers.
    Dallal Bashi YH; McCoy CF; Murphy DJ; Boyd P; Spence P; Kleinbeck K; Devlin B; Malcolm RK
    Int J Pharm; 2019 Oct; 569():118574. PubMed ID: 31352053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring.
    McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
    J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES.
    McBride JW; Malcolm RK; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Devlin B; Boyd P
    Int J Pharm; 2019 Jun; 564():207-213. PubMed ID: 30999049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine.
    Major I; Boyd P; Kilbourne-Brook M; Saxon G; Cohen J; Malcolm RK
    Contraception; 2013 Jul; 88(1):58-66. PubMed ID: 23177261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.
    Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK
    Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
    Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD
    J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology.
    McConville C; Major I; Devlin B; Brimer A
    Eur J Pharm Biopharm; 2016 Jul; 104():171-9. PubMed ID: 27163243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
    Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK
    J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Murphy DJ; Dallal Bashi YH; McCoy CF; Boyd P; Brown L; Martin F; McMullen N; Kleinbeck K; Dangi B; Spence P; Hansraj B; Devlin B; Malcolm RK
    Int J Pharm X; 2022 Dec; 4():100112. PubMed ID: 35128382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel.
    Dallal Bashi YH; Murphy DJ; McCoy CF; Boyd P; Brown L; Kihara M; Martin F; McMullen N; Kleinbeck K; Dangi B; Spence P; Hansraj B; Devlin B; Malcolm RK
    Int J Pharm X; 2021 Dec; 3():100091. PubMed ID: 34977558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel release rates over 5 years with the Liletta® 52-mg intrauterine system.
    Creinin MD; Jansen R; Starr RM; Gobburu J; Gopalakrishnan M; Olariu A
    Contraception; 2016 Oct; 94(4):353-6. PubMed ID: 27125892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
    Clark JT; Clark MR; Shelke NB; Johnson TJ; Smith EM; Andreasen AK; Nebeker JS; Fabian J; Friend DR; Kiser PF
    PLoS One; 2014; 9(3):e88509. PubMed ID: 24599325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel.
    Li J; Regev G; Patel SK; Patton D; Sweeney Y; Graebing P; Grab S; Wang L; Sant V; Rohan LC
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31861267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two into one does go: Formulation development of a multipurpose combination vaginal ring releasing dapivirine and metronidazole for prevention of HIV infection and treatment of bacterial vaginosis.
    Zhao X; Boyd P; Bashi YD; Murphy DJ; McCoy CF; Coulter S; Laverty G; Malcolm RK
    Int J Pharm; 2023 Dec; 648():123572. PubMed ID: 37926178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
    Derby N; Aravantinou M; Kenney J; Ugaonkar SR; Wesenberg A; Wilk J; Kizima L; Rodriguez A; Zhang S; Mizenina O; Levendosky K; Cooney ML; Seidor S; Gettie A; Grasperge B; Blanchard J; Piatak M; Lifson JD; Fernández-Romero J; Zydowsky TM; Robbiani M
    Drug Deliv Transl Res; 2017 Dec; 7(6):840-858. PubMed ID: 28600625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.